Geode Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$46.8M Buy
1,405,755
+11,174
+0.8% +$372K ﹤0.01% 1460
2025
Q1
$40.9M Buy
1,394,581
+44,930
+3% +$1.32M ﹤0.01% 1500
2024
Q4
$44.4M Sell
1,349,651
-7,880
-0.6% -$259K ﹤0.01% 1502
2024
Q3
$60.3M Buy
1,357,531
+6,101
+0.5% +$271K ﹤0.01% 1307
2024
Q2
$58.3M Buy
1,351,430
+68,515
+5% +$2.95M 0.01% 1255
2024
Q1
$37.5M Buy
1,282,915
+28,638
+2% +$837K ﹤0.01% 1550
2023
Q4
$27.9M Buy
1,254,277
+55,317
+5% +$1.23M ﹤0.01% 1715
2023
Q3
$29.7M Buy
1,198,960
+41,293
+4% +$1.02M ﹤0.01% 1563
2023
Q2
$32.8M Buy
1,157,667
+68,308
+6% +$1.93M ﹤0.01% 1525
2023
Q1
$25M Buy
1,089,359
+33,801
+3% +$776K ﹤0.01% 1649
2022
Q4
$29.6M Buy
1,055,558
+28,576
+3% +$802K ﹤0.01% 1507
2022
Q3
$29M Sell
1,026,982
-97,022
-9% -$2.74M ﹤0.01% 1475
2022
Q2
$24.9M Buy
1,124,004
+106,324
+10% +$2.36M ﹤0.01% 1605
2022
Q1
$29.6M Sell
1,017,680
-26,336
-3% -$767K ﹤0.01% 1615
2021
Q4
$34.3M Sell
1,044,016
-3,726
-0.4% -$122K ﹤0.01% 1587
2021
Q3
$48.4M Sell
1,047,742
-1,108
-0.1% -$51.1K 0.01% 1307
2021
Q2
$57.8M Buy
1,048,850
+294,468
+39% +$16.2M 0.01% 1184
2021
Q1
$39M Buy
754,382
+29,151
+4% +$1.51M 0.01% 1428
2020
Q4
$31.4M Buy
725,231
+18,204
+3% +$789K 0.01% 1428
2020
Q3
$24.7M Sell
707,027
-28,626
-4% -$1M ﹤0.01% 1377
2020
Q2
$39.3M Buy
735,653
+10,468
+1% +$560K 0.01% 1026
2020
Q1
$25.7M Buy
725,185
+42,314
+6% +$1.5M 0.01% 1132
2019
Q4
$32.6M Buy
682,871
+95,823
+16% +$4.58M 0.01% 1226
2019
Q3
$19M Buy
587,048
+7,091
+1% +$230K ﹤0.01% 1524
2019
Q2
$28.9M Buy
579,957
+42,922
+8% +$2.14M 0.01% 1227
2019
Q1
$36.2M Sell
537,035
-9,533
-2% -$643K 0.01% 1023
2018
Q4
$25.2M Buy
546,568
+69,603
+15% +$3.21M 0.01% 1120
2018
Q3
$36.8M Buy
476,965
+4,606
+1% +$355K 0.01% 991
2018
Q2
$39.8M Buy
472,359
+48,758
+12% +$4.11M 0.01% 889
2018
Q1
$34.6M Buy
423,601
+54,089
+15% +$4.42M 0.01% 917
2017
Q4
$21.1M Buy
369,512
+4,073
+1% +$233K 0.01% 1236
2017
Q3
$24.4M Buy
365,439
+19,050
+5% +$1.27M 0.01% 1092
2017
Q2
$17.8M Buy
346,389
+82,490
+31% +$4.24M 0.01% 1271
2017
Q1
$15.4M Buy
263,899
+20,336
+8% +$1.19M 0.01% 1346
2016
Q4
$10.2M Buy
243,563
+24,061
+11% +$1M ﹤0.01% 1562
2016
Q3
$11.6M Buy
219,502
+34,732
+19% +$1.83M 0.01% 1395
2016
Q2
$7.74M Buy
184,770
+7,901
+4% +$331K ﹤0.01% 1626
2016
Q1
$7.18K Buy
176,869
+4,325
+3% +$176 ﹤0.01% 1609
2015
Q4
$11.2M Buy
172,544
+8,910
+5% +$578K 0.01% 1301
2015
Q3
$11.6M Buy
163,634
+84,724
+107% +$5.98M 0.01% 1246
2015
Q2
$8.77M Buy
78,910
+409
+0.5% +$45.5K 0.01% 1501
2015
Q1
$7.4M Buy
78,501
+7,999
+11% +$754K ﹤0.01% 1604
2014
Q4
$7.9M Buy
70,502
+9,102
+15% +$1.02M ﹤0.01% 1524
2014
Q3
$3.77M Buy
61,400
+2,057
+3% +$126K ﹤0.01% 1941
2014
Q2
$2.72M Buy
59,343
+20,614
+53% +$945K ﹤0.01% 2193
2014
Q1
$1.52M Buy
38,729
+343
+0.9% +$13.4K ﹤0.01% 2515
2013
Q4
$919K Buy
38,386
+558
+1% +$13.4K ﹤0.01% 2766
2013
Q3
$1.06M Buy
+37,828
New +$1.06M ﹤0.01% 2558